Vidya H Veldore's Biography

• Home
• |
• Registration
• |
• Submissions
  • Submission Guidelines
• |
• Agenda
• |
• Exhibition
• |
• Venue
• |
• Co-Located Conferences
• |

OncoTrackTM - Validation of NGS based Liquid Biopsy Assay for Monitoring Cancer Treatment

Thursday, 25 May 2017 at 12:30

Add to Calendar ▼2017-05-25 12:30:002017-05-25 13:30:00Europe/LondonOncoTrackTM - Validation of NGS based Liquid Biopsy Assay for Monitoring Cancer TreatmentTargeted Cancer Therapies and Biofluid Biopsies in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

This presentation will focus on validation of plasma circulating tumor DNA as biomarker for genomic testing in NSCLC patients: MedGenome in collaboration with India's Premeir Cancer Hospital. Key aspects of validation of a clinical diagnostic assay that includes concordance assessment between tissue biopsy and plasma CtDNA for biomarker status, specificity, sensitivity and diagnostic accuracy of the testing will be discussed.